Skip to main content
PLOS One logoLink to PLOS One
. 2024 May 16;19(5):e0303794. doi: 10.1371/journal.pone.0303794

Malaria prevalence and use of control measures in an area with persistent transmission in Senegal

Fassiatou Tairou 1,*, Ibrahima Gaye 2, Samantha Herrera 3, Saira Nawaz 4, Libasse Sarr 5, Birane Cissé 5, Babacar Faye 1, Roger C K Tine 1
Editor: Sylla Thiam6
PMCID: PMC11098374  PMID: 38753670

Abstract

Introduction

In Senegal, the widespread use of vector control measures has resulted in a significant reduction in the malaria burden and led the country to consider the possibility of elimination. Given this shift and changing context, it is important to characterize the malaria burden across all age groups to guide decision-making on programmatic interventions to interrupt transmission and ultimately eradicate the disease. In Senegal, there is a lack of information on malaria prevalence among certain populations, particularly among adolescents and adults. This study sought to assess the magnitude of malaria infections in all age groups, as well as malaria associated factors in an area of persistent transmission in Senegal.

Methods

A cross-sectional household survey was conducted in four health posts (Khossanto, Mamakhona, Diakhaling and Sambrambougou), of the health district of Saraya, in November 2021, among individuals over 6 months of age. Households were selected using multistage sampling. Consented participants were screened for malaria parasites by microscopic examination of blood smears, and hemoglobin levels were measured using the Hemocue HB 301TM analyzer. Socio-demographic information of the participants, household heads, household assets, and information on ownership and use of preventive measures were collected using a structured questionnaire. Weighted generalized mixed effects logistic regression model was used to identify factors associated with microscopically confirmed malaria infection.

Results

A total of 1759 participants were enrolled in the study. Overall, about 21% of participants were classified as having Plasmodium infection; children aged 5–10 years old (26.6%), adolescents aged 10–19 years old (24.7%), and children under five years of age (20.5%) had higher rates of infection compared to adults (13.5%). Plasmodium falciparum accounted for 99.2% of the malaria infections, and most infections (69%) were asymptomatic. Around one-third of study participants had anemia (hemoglobin level <11.0 g/dl), with under five children bearing the highest burden (67.3%). Multivariate analysis showed that the odds of having a malaria infection were around 2 times higher among participants in Khossanto compared to Diakhaling (aOR = 1.84, 95% CI:1.06–3.20). Participants aged 5–9 years were more likely to have malaria infection compared to under five children (aOR = 1.40, 95% CI:1.02–1.91). Factors associated with anemia were P. falciparum infection (aOR = 1.36, p = 0.027), females (aOR = 2.16, p = 0.000), under-five age group (aOR = 13.01, p = 0.000).

Conclusion

Malaria burden was considerable among adolescents and under ten children living in an area of persistent transmission, with adolescents more commonly presenting as asymptomatic. Interventions tailored to this specific group of the population are needed to better control the disease and reduce its burden.

Introduction

Malaria remains a major public health concern despite important progress made in reducing the disease burden over the past two decades. Sub-Saharan African countries bear the highest share of malaria, with about 94% (233 million) of all cases and 96% (580 000) of all malaria deaths in 2022 [1]. The COVID-19 pandemic has disrupted malaria-related services in many countries and led to an increase in the malaria burden globally, though this has been more predominant in sub-Saharan Africa [2]. Between 2019 and 2020, malaria incidence increased from 222 to 232 per 1000 population at risk in the World Health organization (WHO) African Region and the mortality rate from 57 to 61 deaths per 100 000 population at risk [2]. In 2022, malaria incidence declined to 223 per 1000 population at risk, and the mortality rate to 56 deaths per 100 000 population at risk [1].

In Senegal, malaria is endemic in most of the country, with an upsurge during the rainy season [3]. The disease is unevenly distributed between the fourteen regions of the country. Regions located in the southern part (Kolda, Tambacounda, and Kedougou) recorded 83.3% of cases and 51% of malaria-related deaths in 2020 [4]. Several malaria interventions are being implemented in Senegal including i) diagnosis and treatment using rapid diagnostic tests (RDTs)/microscopy and Artemisinin-based Combination Therapies (ACTs), ii) community case management (“Prise en charge à domicile”- PECADOM and PECADOM plus in specific districts), (iii) vector control with long-lasting insecticidal nets (LLINs) and indoor residual spraying (IRS) in targeted districts, iv) seasonal malaria chemoprevention (SMC) for children under 10 years of age living in eligible areas according to WHO criteria, and (iv) intermittent preventive treatment (IPT) with Sulfadoxine Pyrimethamine (SP) for pregnant women [5,6].

The progress made in the fight against malaria has contributed to a nationwide decrease of malaria burden in Senegal, despite a slight increase in 2020 due to the Covid-19 pandemic [3,6]. Between 2015 to 2019, proportional morbidity (proportion of all-cause consultations associated with parasitologically confirmed malaria) and mortality (proportion of all hospitalized deaths associated with parasitologically confirmed malaria) [5] have decreased from 4.86% and 3.52% to 3.03% and 1.66%, respectively [7]. Due to the substantial reduction in malaria burden, Senegal has outlined a vision of malaria elimination by 2030 in parts of the country where malaria morbidity has fallen sharply and remained at a low level [3]. Senegal captures information on malaria prevalence in children under five and pregnant women through national surveys, including the continuous Demographic and Health Survey (cDHS) and the Malaria Indicator Survey (MIS) [8,9]; however, there is very limited malaria epidemiological data available for all age groups. In addition, these surveys are designed to provide malaria prevalence estimates at a regional level. To guide elimination strategies and intervention planning at subnational level, more granular data are needed.

As Senegal shifts from a control phase to a context of malaria elimination, a better and more granular understanding of the disease pattern across the population is needed, to help support a more targeted approach. In this study, a district-level cross-sectional survey was conducted to assess the magnitude of malaria infection in all age groups, as well as malaria-associated factors in an area of persistent transmission in Senegal.

Methods

Study design and population

A cross-sectional, community-based survey was conducted from 03rd to 18th November 2021, in the health district of Saraya, among individuals over 6 months of age. Individuals who reported living in the study area for at least six months, and who have provided written informed consent (or parents/caregivers consented for the participation of children) were eligible to participate. People who reported a malaria episode and treated with artemisinin-based combination therapy (ACT) in three weeks preceding the study were not enrolled.

Study site

The health district of Saraya is located in the Kedougou region in the south-eastern part of Senegal, at 800 km from the capital, Dakar. The district shares a border with Mali on the east, Guinea in the south, the region of Tambacounda to the north, and the health district of Kedougou to the west. The health district includes 102 villages and occupies a land area of 7803 km2, with an estimated population of 66,017 inhabitants in 2021 [10]. The district has 1 health center, 22 health posts, 28 health huts, and 78 villages with a village volunteer for malaria case management (named “DSDOM”, Dispensateur de soins à domicile). The climate is Sudano-Guinean with a dry season and a rainy season. Malaria is meso endemic and stable in Saraya, with a long transmission season from July to December. Transmission intensity remains high during the rainy season, with a high biting rate (25 bites/person/night) [11] and high morbidity during the transmission period. The major vectors are Anopheles gambiae, An. arabiensis sl, An. funestus and An. nili [12]. Malaria incidence (per 1000 population at risk) was 379.8 in 2019, 607.6 in 2020, and 744.7 in 2021 [4,6]. Within Saraya health district, the study was carried out in the catchment areas of the four health posts that reported the highest number of malaria cases during the previous transmission season in 2020 (Diakhaling, khossanto, Mamakhono, Sambrambougou health posts) (Fig 1).

Fig 1. Health district of Saraya showing the study health posts.

Fig 1

Reprinted from [SARR and al. 2023] under a CC BY license, with permission from [LIBASSE HANE SARR M.], original copyright [2023].

Sample size and sampling method

Assuming a malaria prevalence of 7% among children under five years of age in the study area [9], a sample of 1000 children was calculated to provide a statistical power of 90% and to detect a difference of 3% with an alpha risk of 5% in a two-sided situation.

Thirty clusters represented by fifteen villages in the targeted health posts were selected using a two-level random cluster sampling approach with probability proportional to size in the villages. After the selection of the clusters, households were selected using the compact segment sampling technique. A map of each selected village was drawn and divided into segments, so that each segment included approximately 63 persons aged 6 months or older (in total, in all age groups) including 33 persons aged under 20 years old. The number of segments in each village was calculated as the approximate village total population divided by 63, rounded down to the nearest whole number [13,14]. The segment to be surveyed was then randomly selected, its boundaries were transformed in shape file and integrated in the LOCUS MAP navigation software to be easily identified in the field. All the households in the segment were visited and all the individuals over 6 months of age who provided written informed consent for study participation were enrolled in the survey. Written informed consent was obtained from parents for participants below the age of 18 years old.

The number of persons to be recruited from each of the following age groups (6 months-9 years, 10 to 19 years, and >20 years) was determined by applying the percentage of representability of each age group in the Senegalese population [15] to the sample size calculated.

Data collection

The study questionnaire was developed in French and deployed in an electronic form using Open Data Kit (ODK), and included information on the demographics (age, gender, village, ethnicity, education level, and occupation) of the participants and those of their household head (age, gender, occupation, education level), the household characteristics (GPS coordinates, type of wall, roof, floor, water source, type of toilet), as well as the assets of the household. In addition, data on the travel history of the participants outside the village in the previous four weeks and participants’ use of malaria preventive methods (bed net ownership and usage, use of other malaria preventive measures such as coils, repellents, wearing of long clothes, hand cream, cleaning of sewage) was collected. Furthermore, information on the receipt of seasonal malaria chemoprevention (SMC) during the 2021 campaign (four rounds) was collected for children aged 6 months to 10 years, based on caregiver/mother report. The questionnaire was piloted in Saraya city in an area that was not included in the survey, to check for understanding and accuracy of the questions by the population and was then adapted in accordance with findings from the piloting. The questionnaire was administered to the participants by trained enumerators, using android tablets. The main outcome measures included the prevalence of malaria parasitemia and anemia.

Sample collection and laboratory methods

The team in charge of the sample collection and the preparation of the blood smears was composed of two experienced laboratory technicians from the department of medical parasitology of Université Cheikh Anta Diop (UCAD) of Dakar, supported by trained community health worker. A blood sample was taken from each participant by finger prick. Two slides with both thick and thin smears were prepared for each participant. The slides were dried at room temperature, and the thin smears were fixed with methanol. Both thin and thick smears were stained with 10% Giemsa for 15 minutes on the site to ensure their quality and integrity. The slides were then read at the laboratory of medical parasitology of UCAD (the National Malaria Reference Laboratory) by experienced microscopists. Each slide was read by two independent microscopists. The species (Plasmodium (P). falciparum, P. malariae, P. vivax, or P. ovale) and the stade (asexual and sexual) for each positive slide were determined. The parasite density (per μl) was assessed for asexual parasites by counting the number of parasites per 200/500 white blood cells, as follows: (Number of parasites counted X 8000)/number of leukocytes counted. In case of a discrepancy between the two readings (positive versus negative or a difference of more than 10% on the parasite density), a 3rd reading was performed by another microscopist. The final parasite density was the average of the parasite densities of the two closer readings.

A malaria rapid diagnosis test (RDT) was performed for those with fever (axillary temperature ≥37.5°C) or a history of fever in the previous 48 hours, using P. falciparum histidine-rich protein 2 (PfHRP2) test (mRDT- SD Bioline).

Hemoglobin level was measured for each participant using a portable hemoglobinometer. A drop of finger prick blood was drawn into a microcuvette for hemoglobin determination using the HemoCue® machine (HemoCue® AB Hb 301, Ängelholm, Sweden).

Data management and statistical analysis

A unique identifier was attributed to each participant and used to label the samples. The data collected were checked for completeness and consistency. Cleaned data were analyzed using STATA software (Stata Corp 2016). Continuous variables were summarized into means ± standard deviation (SD), and categorical variables into frequencies and proportions. Means were compared using Student’s t-test and proportions using Pearson’s Chi-square test.

A multistage sampling technique, known as a complex survey design was used in this survey. Thus ordinary logistic regression is not appropriate for the modeling of such survey data [1618]. To take into consideration the complexity of the survey design, a weighted generalized mixed effects logistic regression model was used to explore potential determinants of malaria and factors associated with anemia among the study population. All two-way interactions formed by the independent variables were assessed. Significant variables with p≤0.25 in univariate analysis were introduced in the multivariate analysis. Calibration statistics were computed to assess the model fit, and the R-squared was 0.94, indicating a good model fit [19,20]. The selection of the final model was based on criteria such as Akaike’s information criterion (AIC) and Bayesian information criterion (BIC) [16,18]. The significance level for the final model was set at 5% (two-sided).

Response variable: the dependent variable was binary, it referred to the result of microscopy and indicated whether the participant was tested positive (1) or negative (0) for malaria.

Independent variables: explanatory variables consisted of the socio-demographic characteristics of the participant (age, gender), those of the household head (education level, wealth index, gender), household characteristics and assets (e.g., type of wall, type of floor, type of roof, household ownership of different materials or goods), the number of persons in the household, possession of bed net and its use the night before the survey, the location of the health post, history of travel outside of the village.

The primary outcome was the prevalence of P. falciparum infection confirmed by microscopy. Secondary outcomes included: the prevalence of symptomatic malaria, the prevalence of asymptomatic malaria, and the prevalence of anemia.

Definition of terms. Asymptomatic malaria was defined as individuals who were microscopy positive, with a temperature below 37.5°C and absence of malaria-related symptoms [21].

Symptomatic malaria was defined as individuals with microscopically confirmed infection and an axillary temperature >37.5°C [22].

Anemia was defined as a hemoglobin count less than 11 grams per deciliter (g/dl) and was categorized as severe (Hb level < 8.0 g/dl), and moderate (between 8 and 11 g/dl) [23].

Parasite density was categorized as low (< 5000) and high (≥ 5000) density.

Full SMC coverage was defined as proportion of children aged 6 months to 10 years who received the complete 3 days treatment course for all four rounds.

The wealth index was calculated based on the household assets (water source, type of toilet, ownership of radio, TV, bicycle, fridge, combustible) and household characteristics (type of wall, type of floor, type of roof), using a principal component analysis [24,25]. The index was then categorized into five levels (highest, fourth, middle, second, lowest).

Ethical considerations

The study protocol was approved by the Institutional Ethics Committee of University Cheikh Anta Diop of Dakar (CER/UCAD/AD/MSN /039/2020). Administrative authorization was sought from the health district of Saraya, and from the community’s leaders to conduct the study in their area and for the participation of the community. Participation in the study was voluntary. Prior to each participant’s enrollment, written informed consent was sought from the parents/guardians of all children, aged 6 months to 17 years old for their child’s participation. In addition, written assent was sought from participants 15–17 years old of age. Furthermore, older adolescents and adults, aged 18 years old and more were invited to provide written informed consent to participate. No personal identifiable data was collected; a unique identifier was attributed to each participant. All the data collected for the study was kept confidential, and used only for the study purpose, and access was restricted to the study staff. During the course of the survey, participants who were found with moderate anemia (hemoglobin <11 g/dl) were treated as per national guidelines, and those with severe anemia (hemoglobin <8g/dl) were referred to the district health center for treatment. Individuals with positive RDTs were treated, with artemether-lumefantrine (AL) according to the national guidelines. The required treatments for patients with malaria and anemia were covered by the study.

Results

Characteristics of the study participants

A total of 1759 participants were enrolled in the study, among which 22.1% were from the Diakhaling health post, 30.8% from Khossanto, 27.8% from Mamakhono and 19.3% from Sambrambougou. Twenty percent of the participants were below 5 years of age, 23.7% were 5–9 years old, 13.2% were 10–14 years old, 9.1% were 15–19 years old, and 33.7% were 20 years old and above. Just over half of the participants were female (54.1%); the Malinke ethnicity represented 77.4% of the survey sample. Just under half of the participants had received no formal education (46.6%), or had no formal occupation (43%)

According to the report of caregivers/mothers, a proportion of sixty-eight percent (68.8%) of children aged 6 months to 10 years (n = 839) received at least one dose of SMC; full coverage of SMC (3 days of treatment for all four rounds) was evaluated at 46.8% (Table 1).

Table 1. Socio-demographics characteristics of the study participants.

Variables Overall, N = 1759 6 months to <5 years, n = 356 5 to <10 years, n = 417 10 to <15 years, n = 232 15 to 19 years, n = 160 > = 20 years, n = 594
Characteristics of the participants
Sex
Female 951(54.1) 177(49.7) 219(52.5) 119(51.3) 101(63.1) 335(56.4)
Ethnicity
Malinke 1362(77.4) 283(79.5) 348(83.5) 189(81.5) 117(73.1) 425(71.6)
Pular 233(13.3) 47(13.2) 50(12.0) 33(14.2) 29(18.1) 74(12.5)
Other* 164(9.3) 26(7.3) 19(4.6) 10(4.3) 14(8.8) 95(16.0)
Education level
None 820(46.6) 356(100.0) 135(32.4) 27(11.6) 41(25.6) 261(43.9)
Koranic school 193(11.0) ‐‐ 34(8.2) 29(12.5) 23(14.4) 107(18.0)
Primary 650(36.9) ‐‐ 237(56.8% 172(74.1) 66(41.3) 175(29.5)
Secondary 82(4.7) ‐‐ ‐‐ 4(1.7) 30(18.8) 48(8.1)
University 03(0.2) ‐‐ ‐‐ ‐‐ ‐‐ 03(0.5)
OtherΨ 11(0.7) ‐‐ 11(2.6) ‐‐ ‐‐ ‐‐
Occupation
None 759(43.2) 356(100.0) 140(33.6) 47(20.3) 67(41.9) 149(25.1)
Farmer 143(8.1) ‐‐ 03(0.7) 02(0.9) 12(7.5) 126(21.2)
Student 452(25.7) ‐‐ 261(62.6) 160(68.9) 28(17.5) 03(0.5)
Gold digger 276(15.7) ‐‐ 03(0.7) 09(3.9) 36(22.5) 228(38.4)
Vendor/trader 54(3.1) ‐‐ 01(0.2) 06(2.6) 04(7.4) 40(6.8)
Worker 52(2.9) ‐‐ 07(1.7) 06(2.6) 04(7.4) 32(5.4)
Other# 23(1.3) ‐‐ 02(0.5) 02(0.9) 03(1.9) 16(2.7)
History of travel in the previous 4 weeks 169(9.6) 21(5.9) 29(6.9) 19(8.2) 16(10.0) 84(14.1)
SMC receipt in 2021
Yes 577(68.8)Φ 244(68.5) 304(72.9) 29(43.9)δ ‐‐ ‐‐
No 262(31.2)Φ 112(31.5) 113(27.1) 37(56.0)δ ‐‐ ‐‐
SMC full treatment course 393(46.8)Φ 160(44.9) 214(51.3) 19(28.8)δ ‐‐ ‐‐
Characteristics of the household’s head
Age-means (SD) 45.5(15.5)  45.6(15.6)  47.8(14.0)  49.4(13.8)  44.2(16.0)  43.0(16.3)
Sex
Male 1641(93.3) 325(91.3) 393(94.2) 217(93.5) 147(91.9) 559(94.1)
Female 106(6.0) 24(6.7) 22(5.3) 13(5.6) 12(7.5) 35(5.9)
Missing 12(0.7) 07(2.0) 02(0.5) 02(0.9) 01(0.6) ‐‐
Education level
None 700(39.8) 141(39.6) 161(38.6) 100(43.1) 64(40.0) 235(39.6)
Koranic school 588(33.4) 119(33.4) 138(33.1) 79(34.1) 56(35.0) 196(33.0)
Primary 426(24.2) 83(23.3) 113(27.1) 48(20.7) 33(20.6) 149(25.1)
Secondary 32(1.8) 06(1.7) 03(0.7) 03(1.3) 06(3.7) 14(2.4)
University 01(0.1) ‐‐ ‐‐ ‐‐ ‐‐ 01(0.2)
Missing 12(07) 07(2.0) 02(0.5) 02(0.9) 01(0.6) ‐‐
Occupation
None 109(6.2) 22(6.2) 33(7.9) 09(3.9) 08(5.0) 37(6.2)
Farmer 762(43.3) 160(45.0) 200(48.0) 104(44.8) 65(40.6) 233(39.2)
Gold digger 617(35.1) 118(33.2) 123(29.5) 59(36.9) 136(34.7) 240(40.4)
Vendor/trader 80(4.6) 15(4.2) 18(4.3) 13(5.6) 08(5.0) 26(4.4%
Worker 100(5.7) 20(5.6) 22(5.3) 13(5.6) 09(5.6) 36(6.1)
Other$ 79(4.5) 14(3.9) 19(4.6) 14(6.0) 10(6.3) 22(3.7)
Missing 12(0.7) 07(2.0) 02(0.5) 02(0.9) 01(0.6) ‐‐
Wealth index
Highest 351(19.9) 74(20.8) 93(22.3) 44(19.0) 34(21.3) 106(17.9)
Fourth 352(20.0) 77(21.6) 90(21.6) 47(20.3) 29(18.0) 109(18.4)
Middle 352(20.0) 68(19.1) 99(23.7) 52(22.4) 31(19.4) 102(17.2)
Second 352(20.0) 70(19.7) 83(19.9) 51(22.0) 30(18.8) 118(19.9)
Lowest 352(20.0) 67(18.8) 52(12.5) 38(16.4) 36(22.5) 159(26.8)

*Dialounke, Bambara, Dogon, Bosso, Diola, Serere, Bassari, Wolof and Mossi.

Ψ Preschool.

# Household wife, driver, community health worker, Koranic teacher.

$ Electrician, community health worker, butcher, imam, tailor, village chief.

Φ Percentage based on the total number (839) of children aged ≤ 10 years.

δ Percentage based on the number (66) of children aged 10 years.

Ownership, usage of LLINs, and other preventive measures

Overall, about half of participants (49.4%) reported that their household owned a LLIN; with household ownership of bed nets slightly lower among adolescent participants 15–19 years of age (40.6%) (Fig 2).

Fig 2. Household bed net ownership and individual bed net use.

Fig 2

The percentage of participants who reported using a LLIN the night before the survey was 43.1%. LLIN use was reported to be the highest among participants below five years of age and 20 years of age and above (about 48%) (Fig 2).

Forty-two percent of the participants, reported using other malaria preventive measures. Of those that reported using other preventive measures, the most common measures included coils (66.4%), insecticide spray (32.1%), and wearing long clothes (26.9%).

Prevalence of malaria parasitemia among the study participants

Overall, the prevalence of Plasmodium infection. was 20.5% among the study participants. The highest prevalence was observed among children 5–9 years of age (26.6%), followed by adolescents aged 10–19 years (24.7%) and under-five children (20.5%). Adults 20 years of age and above had the lowest parasite prevalence, at 13.5%.

The highest geometric mean density of P. falciparum parasites, 3322.4 (2202.0–5012.8) was observed among children aged 5–9 years old.

P. falciparum was the predominant parasite species, accounting for 99.2% of malaria infections. In addition to P. falciparum, three individuals among the study participants harbored other Plasmodium species, 2 had mixed infections (0.11%) with P falciparum and P. malaria, and 1 had a mixed infection (0.06%) with P. falciparum and P. ovale.

A total number of 43 individuals were found with gametocytes, providing a prevalence of gametocyte carriage at 2.4% among the study participants. Age distribution of gametocyte carriage was as follow: 2.8% for under five children, 3.4% for 5–9 years old children, 2.5% for 10–19 years old adolescents, and 1.5% among adults above the age of 20 years.

The overall prevalence of asymptomatic Plasmodium infection was 14.2% among the study participants. Asymptomatic P. infection was highest among children 5–9 years of age (17.0%) and adolescents 10–19 years of age (18.4%), compared to children under-five (11.8%) and adults 20 years of age and above (10.9%).

The prevalence of symptomatic Plasmodium infection was 6.3% in the study. Symptomatic P. infection was highest among children under-five of age (8.7%) and children 5–9 years of age (9.6%) (Table 2).

Table 2. Prevalence of malaria infection among the study participants by age group.

Parameters
N (%)
Overall, N = 1759 6 months to <5 years, n = 356 5 to <10 years, n = 417 10 to <15 years, n = 232 15 to 19 years, n = 160 > = 20 years, n = 594
Fever (Temperature ≥ 37.5) 289(16.9) 77(21.60 75(17.9) 37(15.9) 19(11.9) 81(13.6)
Plasmodium infection
Plasmodium (P.) infection 361(20.5) 73(20.5) 111(26.6) 57(24.6) 40(25.0) 80(13.5)
Asymptomatic P. infection 250(14.2) 42(11.8) 71(17.0) 37(15.9) 35(21.9) 65(10.9)
Symptomatic P. infection 111(6.3) 31(8.7) 40(9.6) 20(8.6) 5(3.1) 15(2.5)
P. falciparum 358(20.4) 72(20.2) 111(26.6) 56(24.1) 39(24.4) 80(13.5)
Mixed infection (P falciparum+ P. malariae) ‐‐ 01(0.3) ‐‐ 01(0.4) ‐‐ ‐‐
Mixed infection (P falciparum + P. Ovale) ‐‐ ‐‐ ‐‐ ‐‐ 01(0.6) ‐‐
Geometric means of P. falciparum density 1440.9
(1146.9–1810.2)
1553.64(918.2–2628.9) 3322.36(2201.9–5012.8) 1498.94(857.4–2620.7) 542.66(300.1–981.2) 643.65(416.7–994.2)
Prevalence of P. falciparum gametocyte 43(2.4) 10(2.8) 14(3.4) 05(2.2) 05(3.1) 09(1.5)

The prevalence of P. falciparum malaria infection was highest in Khossanto at 26.4% (22.5% -30.3%) and lowest in Diakhaling at 15.2% (11.9% -19.1%) (Fig 3).

Fig 3. Prevalence of malaria infection by health post.

Fig 3

Prevalence of anemia among the study participants

Hemoglobin was measured for 1723 participants; out of these, 33.5% were anemic (Hb < 11g/dL), with 29.8% with moderate anemia and 3.8% with severe anemia. Under-five children had the highest rate of anemia (67.3%), compared to other age groups (Fig 4).

Fig 4. Prevalence of anemia by age group.

Fig 4

The prevalence of anemia was similar across the 4 health posts (ranging from around 28.8% in Sambrambougou to 35.1% in Mamakhono).

Factors associated with malaria infection

In a multivariate analysis, children aged 5–9 years were 1.40 times more likely to have malaria compared to their under five years counterparts (aOR = 1.40, 95% CI: 1.02–1.91) while adults aged 20 years and over (≥20) were less likely to have malaria infection than children under five (aOR = 0.64, 95% CI: 0.46–0.90).

The odds of having malaria parasites was higher in the health post of Khossanto (aOR = 1.84, 95% CI: 1.06–3.20) compared to Diakhaling (Table 3).

Table 3. Estimates and odds ratios (OR) with 95% confidence intervals.

Parameters Estimates OR 95% CI P-value
Intercept -2.10 0.000
Age (years) (Ref. reference, age 0.5 to <5)
5 to <10 0.34 1.40 1.02–1.91 0.035
10 to <15 0.25 1.28 0.88–1.87 0.198
15 to <20 0.30 1.35 0.91–1.99 0.135
≥ 20 -0.44  0.64 0.46–0.90 0.010
Gender (Ref. Female)
Male 0.18  1.19 0.88–1.61  0.253
Household head education (Ref. No education)
Koranic 0.04 1.04 0.74–1.48 0.807
Primary 0.23 1.26 0.92–1.73 0.150
Secondary -0.44  0.64 0.22–1.92 0.430
Health post (Ref. Diakhaling)
Khossanto 0.61 1.84 1.06–3.20 0.030
Mamakhono 0.22 1.25 0.78–2.02 0.359
Sambrambougou 0.23 1.26 0.79–2.02 0.337
Use of bed net the
previous night (Ref. Yes)
No 0.10 1.10 0.79–1.54 0.555
Number of household members (continuous) 0.007 1.01
1.00–1.02
0.136

Factors associated with anemia among the study participants

Table 4 presents the multivariate analysis of the factors associated with anemia. Individuals with positive infection by P. falciparum were more at risk of anemia (aOR = 1.36, p = 0.027) compared to individuals who were not P. falciparum positive. Female individuals were more likely to be anemic (aOR = 2.16, p = 0.000), compared to their male counterparts. Anemia risk significantly decreased as the age of the individual increased; the odds of anemia were 13 times (aOR = 13.01, p = 0.000) higher among under-five children compared to adults aged 20 years old and above. The odds of anemia were around 3 times (aOR = 3.35, p = 0.000) and 2 times higher (aOR = 1.99, p = 0.001) respectively, among children aged 5–9 years old and adolescents aged 10–14 years old, compared to adults 20 years of age and above.

Table 4. Logistic regression of factors associated with anemia among the participants in Saraya health district.

Parameters Estimates OR 95% CI P-value
Intercept -2.33 0.000
Age (years) (Ref. reference, age > = 20)
0.5 to <5
2.57 13.01
9.26–18.28
0.000
5 to <10 1.21 3.35 2.34–4.78 0.000
10 to <15 0.69 1.99 1.34–2.96 0.001
15 to <20 0.26 1.30 0.76–2.23 0.343
Gender (Ref. Male)
Female 0.77  2.16 1.68–2.78  0.000
Malaria parasite (Ref. Absence)
Presence 0.31 1.36 1.04–1.79 0.027
Use of bed net the
previous night (Ref. Yes)
No 0.22 1.25 0.92–1.70 0.153

Discussion

As countries shift from control to pre-elimination phase, assessing the magnitude of malaria infection in all age groups has become crucial, for a more targeted approach to intervention delivery. To the best of our knowledge, there is limited data on parasite prevalence among adolescents and adults in Senegal. This cross-sectional survey was thus conducted to evaluate the prevalence of malaria infections among a population living in an area with persistent malaria transmission in Senegal and included adolescents and other understudied groups of the population, to generate evidence to help guide future malaria interventions.

The study revealed a high burden of malaria infection with an overall prevalence of P. falciparum infection of 20% among the study participants. Though no statistical difference was found in term of malaria prevalence between children aged under ten and adolescents (aged 10 to 19 years of age), adolescents were found to have a high infection rate, suggesting that adolescents may represent an important source of malaria reservoir and could be potential drivers of malaria infections. Moreover, despite a higher risk of malaria infection, adolescents remained under-protected with the lowest rate of LLIN usage compared to other population groups. Other studies conducted in the same area revealed sub-optimal care-seeking behavior for fever management among adolescents as well as a low uptake of malaria preventive measures [26,27]. These data call for an urgent need to develop specific interventions targeting these new emerging vulnerable groups, that continue to be missed by health care interventions. Most malaria interventions in Senegal, continue to target common at-risk populations such as children under five and pregnant women. Children under 10 are currently being targeted by specific control interventions such as seasonal malaria chemoprevention (SMC), extending SMC to adolescents could be considered by NMCP in Senegal for effective control of malaria infections.

It was noted that most of the P. falciparum malaria infections (69.3%) were asymptomatic, with the highest proportion among 15–19 years old adolescents (87.5%) and adults over 20 years. This could be explained by the acquisition of partial immunity, due to recurrent exposure to mosquito bites [28,29]. Asymptomatic infections constitute a threat for malaria control, as such infections can persist for months, specifically among older age groups, and will not be detected and therefore could remain untreated. As a consequence, these individuals serve as parasite reservoirs and can continue to sustain transmission in the community [28,30,31]. In this context, developing new approaches that will target asymptomatic infections alongside existing interventions could be important to accelerate malaria control and elimination. An enhanced community-based surveillance system, or a strategy of screening and provision of treatment could be useful within this epidemiological context. Both of these interventions have been shown to be promising for malaria control and elimination in Senegal [32]. However, the proportion of symptomatic malaria infection was high among small (under five) and school-age (5–14 years old) children, and could be explained by their increased susceptibility to the parasite due to low or lack of immunity [33].

LLIN ownership in the study area remained low in the entire study population with an overall household bed net ownership at 49.5%, which is below the NMCP strategic target of 80% [3]. This may be explained by the fact that the last mass campaign of long-lasting insecticide nets (LLIN) was conducted three years prior to the survey, and the subsequent one was planned at the time of the survey. Studies on the durability of LLIN revealed that the median survival time of LLIN in Senegal was at 2.4 years [34], demonstrating the need for malaria programs to develop alternative strategies that can help maintain high LLIN coverage between mass campaigns. This study also revealed a gap between ownership and use of the LLIN, with only 43% of the participants reporting using the bed net. It appears that there is still a gap between ownership and usage of LLIN as reported by several malaria programs in Sub-Saharan Africa [35]. Operational research could be helpful to understand why there is still a persistent gap between net ownership and net usage despite significant efforts by malaria programs to improve net usage [35].

Malaria exposure seems to be more pronounced in one health post compared to other study areas suggesting a spatial heterogeneity in terms of malaria distribution. Establishing a surveillance system that can provide real-time identification of malaria hotspots is therefore needed. Malaria surveillance in many settings in Senegal relies mainly on aggregate data of malaria cases from routine outpatient visits at health facilities and cross-sectional community household surveys to assess malaria prevalence. Such a system may not be efficient to accurately characterize the disease epidemiology, especially when transmission is so spatially heterogeneous. Further efforts are thus needed to strengthen surveillance systems for a more targeted approach of anti-malaria interventions delivery.

Around one-third (33.5%) of the study participants were anemic, including 89% presenting moderate anemia. The highest anemia rate was observed among children under ten years old, and anemia remained closely associated with malaria infection as described in previous studies [3640]. However, three-quarters of anemic participants in the present study were P. falciparum negative. Anemia etiologies are multifactorial and other factors including soil-transmitted helminthiasis [37,41], and stunting [42,43] could explain the high prevalence of anemia observed among these non-malaria participants but our study did not assess these factors. Prevalence of anemia decreased with an increase in age in our study. Similar results have been shown in other studies [37,39,44,45]. Iron deficiency due to the high demand for iron by the body during the childhood, and/or the loss of iron due to parasitic infections such as malaria and intestinal worms may explain this result [41,46]. Being female was associated with a higher risk of anemia; biological differences between females and males may explain this result [47,48].

Study limitation

There are a number of limitations to this study. Submicroscopic malaria infections were not assessed. Molecular studies to evaluate their magnitude and their potential contribution to disease transmission might provide additional epidemiological data relevant to the study settings.

The study did not collect data on entomological features and on environmental factors including temperature, humidity, rainfall that may influence malaria distribution. Such data would help to better evaluate the spatial heterogeneity of malaria transmission dynamics.

Conclusion

The prevalence of P. falciparum infection was high among adolescents and children under ten; with adolescents more commonly presenting as asymptomatic. Interventions tailored to adolescents are needed to optimize malaria control. Additional interventions such as extending SMC to adolescents, developing a strategy for screening and treatment of adolescents as well as an enhanced community-based surveillance for fever case management could be options to consider. Operational research would be useful to assess the feasibility and potential impact of such approaches.

Supporting information

S1 Checklist. STROBE statement—checklist of items that should be included in reports of cross-sectional studies.

(DOCX)

pone.0303794.s001.docx (31.7KB, docx)
S1 File. French version of the study questionnaire.

(DOCX)

pone.0303794.s002.docx (44KB, docx)
S2 File. English version of the study questionnaire.

(DOCX)

pone.0303794.s003.docx (33.1KB, docx)
S1 Dataset. Prevalence survey excel dataset.

(XLSX)

pone.0303794.s004.xlsx (1.8MB, xlsx)

Acknowledgments

The authors acknowledge Dr Baba Camara, Head of the District Health of Saraya, and his team who facilitated the conduct of the study in the health district, as well as the population of the study area for their participation in the study.

Data Availability

All relevant data are within the manuscript and its Supporting Information files

Funding Statement

The study was supported by the Senegalese National Malaria Control Program, through an agreement with the Department of Parasitology and Mycology of University Cheikh Anta Diop of Dakar (# funding number: NFM 2-SEN-M-PNLP 2018 - 2019 -2020). The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Wrold Health Organization (WHO). World malaria report 2023. Geneva.
  • 2.World Health Organisation. World malaria report 2022. Geneva; 2022.
  • 3.Programme National de Lutte contre le Paludisme (PNLP). Plan Stratégique National de Lutte contre la Paludisme au Senegal, 2021–2025 [Internet]. 2020. Available from: https://senegal-cocreation.com/wp-content/uploads/2021/02/PSN_PNLP_Senegal_Version-finale_-Fevrier-2021.pdf.
  • 4.Programme National de Lutte contre le Paludisme (PNLP). Bulletin Epdidemiologique annuel 2020 du paludisne au Sénégal. 2021 Mar p. 2–61.
  • 5.Thwing J, Eckert E, Dione DA, Tine R, Faye A, Yé Y, et al. Declines in Malaria Burden and All-Cause Child Mortality following Increases in Control Interventions in Senegal, 2005–2010. The American Journal of Tropical Medicine and Hygiene. 2017;97:89–98. doi: 10.4269/ajtmh.16-0953 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Programme National de Lutte contre le paludisme (PNLP). Bulletin Epidemiologique annuel 2021 du paludisme au Sénégal [Internet]. 2022 Mar p. 1–76. Available from: https://pnlp.sn/bulletin-epidemiologique-annuel/.
  • 7.Programme National de Lutte contre le Paludisme (PNLP). Bulletin épidémiologique annuel 2019 du paludisme au Sénégal. Sénégal; 2020 Février p. 2–54.
  • 8.Agence nationale de la Statistique et de la Démographie (ANSD), Programme National de Lutte contre le Paludisme (PNLP), l’Agence des Etats Unis pour le Développement international (USAID), Fond mondial et ICF. Enquête sur les Indicateurs du Paludisme au Sénégal, 2020–2021. Rockville, Maryland, USA: ANSD, PNLP, USAID, FM et ICF; 2021.
  • 9.Agence Nationale de la Statistique et de la Démographie (ANSD) [Sénégal], et ICF. Enquête Démographique et de Santé Continue (EDS-Continue 2019). Senegal. Rockville, Maryland, USA; 2019.
  • 10.Agence Nationale de la Statistique et de la Démographie (ANSD) [Sénégal], et ICF. Projection de la population de la région de Dakar ‐ 2013–2025 [Internet]. [cited 2022 Jan 22]. Available from: http://www.ansd.sn/ressources/publications/indicateurs/Projections-demographiques-2013-2025+.htm.
  • 11.The PMI VectorLink Project, Abt Associates Inc. VectorLink Senegal Final Entomological Report: January 1, 2019 –January 31, 2020. [Internet]. Rockville, MD; 2020 Mar. Available from: https://www.pmi.gov/docs/default-source/default-document-library/implementing-partner-reports/senegal-2019-entomological-monitoring-final-report.pdf?sfvrsn=4
  • 12.Programme National de Lutte contre le paludisme (PNLP). Plan Sytratégique National de Lutte contre le Paludisme au Sénégal, 2016–2020. 2015 Oct.
  • 13.Milligan P, Njie A, Bennett S. Comparison of two cluster sampling methods for health surveys in developing countries. Int J Epidemiol. 2004;33:469–76. doi: 10.1093/ije/dyh096 [DOI] [PubMed] [Google Scholar]
  • 14.Kuper H, Polack S, Limburg H. Rapid Assessment of Avoidable Blindness. Community Eye Health J. 2006;19. [PMC free article] [PubMed] [Google Scholar]
  • 15.Agence Nationale de la Statistique et de la Démographie (ANSD). Rapport annuel sur la population du Sénégal en 2020 [Internet]. 2020. Available from: https://www.ansd.sn/Indicateur/donnees-de-population.
  • 16.Roberts D, Matthews G. Risk factors of malaria in children under the age of five years old in Uganda. Malar J. 2016;15:246. doi: 10.1186/s12936-016-1290-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ugwu CLJ, Zewotir TT. Using mixed effects logistic regression models for complex survey data on malaria rapid diagnostic test results. Malar J. 2018;17:453. doi: 10.1186/s12936-018-2604-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Habyarimana F, Ramroop S. Prevalence and Risk Factors Associated with Malaria among Children Aged Six Months to 14 Years Old in Rwanda: Evidence from 2017 Rwanda Malaria Indicator Survey. IJERPH. 2020;17:7975. doi: 10.3390/ijerph17217975 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. Journal of Clinical Epidemiology. 2016;74:167–76. doi: 10.1016/j.jclinepi.2015.12.005 [DOI] [PubMed] [Google Scholar]
  • 20.Lunevicius R, Nzenwa IC. Multiple logistic regression model to predict bile leak associated with subtotal cholecystectomy. Surg Endosc. 2023;37:5405–13. doi: 10.1007/s00464-023-10049-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mensah BA, Myers-Hansen JL, Obeng Amoako E, Opoku M, Abuaku BK, Ghansah A. Prevalence and risk factors associated with asymptomatic malaria among school children: repeated cross-sectional surveys of school children in two ecological zones in Ghana. BMC Public Health. 2021;21:1697. doi: 10.1186/s12889-021-11714-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Yaro JB, Tiono AB, Ouedraogo A, Lambert B, Ouedraogo ZA, Diarra A, et al. Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention. Sci Rep. 2022;12:1402. doi: 10.1038/s41598-022-05056-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.The DHS Program. Guide to DHS Statistics DHS-7: Anemia Status [Internet]. [cited 2022 Nov 6]. Available from: https://dhsprogram.com/data/Guide-to-DHS-Statistics/Anemia_Status.htm
  • 24.Sixpence A, Nkoka O, Chirwa GC, Milanzi EB, Mangani C, Mathanga DP, et al. Levels of knowledge regarding malaria causes, symptoms, and prevention measures among Malawian women of reproductive age. Malar J. 2020;19:225. doi: 10.1186/s12936-020-03294-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Houngbedji CA, N’Dri PB, Hürlimann E, Yapi RB, Silué KD, Soro G, et al. Disparities of Plasmodium falciparum infection, malaria-related morbidity and access to malaria prevention and treatment among school-aged children: a national cross-sectional survey in Côte d’Ivoire. Malar J. 2015;14:7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Tairou F, Diallo A, Sy O, Kone A, Manga IA, Sylla K, et al. Malaria-associated risk factors among adolescents living in areas with persistent transmission in Senegal: a case–control study. Malar J. 2022;21:193. doi: 10.1186/s12936-022-04212-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Tairou F, Nawaz S, Tahita MC, Herrera S, Faye B, Tine RCK. Malaria prevention knowledge, attitudes, and practices (KAP) among adolescents living in an area of persistent transmission in Senegal: Results from a cross-sectional study. PLoS One. 2022;17:e0274656. doi: 10.1371/journal.pone.0274656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Mendonça VR de, Barral-Netto M. Immunoregulation in human malaria: the challenge of understanding asymptomatic infection. Mem Inst Oswaldo Cruz. 2015;110:945–55. doi: 10.1590/0074-02760150241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Zaw MT, Thant M, Hlaing TM, Aung NZ, Thu M, Phumchuea K, et al. Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar. Malar J. 2017;16:138. doi: 10.1186/s12936-017-1789-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lennon SE, Miranda A, Henao J, Vallejo AF, Perez J, Alvarez A, et al. Malaria elimination challenges in Mesoamerica: evidence of submicroscopic malaria reservoirs in Guatemala. Malar J. 2016;15:441. doi: 10.1186/s12936-016-1500-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Buchwald AG, Sorkin JD, Sixpence A, Chimenya M, Damson M, Wilson ML, et al. Association Between Age and Plasmodium falciparum Infection Dynamics. American Journal of Epidemiology. 2019;188:169–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Conner RO, Dieye Y, Hainsworth M, Tall A, Cissé B, Faye F, et al. Mass testing and treatment for malaria followed by weekly fever screening, testing and treatment in Northern Senegal: feasibility, cost and impact. Malar J. 2020;19:252. doi: 10.1186/s12936-020-03313-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Abossie A, Yohanes T, Nedu A, Tafesse W, Damitie M. Prevalence of Malaria and Associated Risk Factors Among Febrile Children Under Five Years: A Cross-Sectional Study in Arba Minch Zuria District, South Ethiopia. IDR. 2020;Volume 13:363–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Diouf M, Faye BT, Diouf EH, Dia AK, Konate A, Fall FB, et al. Survival of eight LLIN brands 6, 12, 24 and 36 months after a mass distribution campaign in rural and urban settings in Senegal. BMC Public Health. 2022;22:719. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Tine R, Herrera S, Badji MA, Daniels K, Ndiaye P, Smith Gueye C, et al. Defining operational research priorities to improve malaria control and elimination in sub-Saharan Africa: results from a country-driven research prioritization setting process. Malar J. 2023;22:219. doi: 10.1186/s12936-023-04654-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Tine RCK, Ndiaye M, Hansson HH, Ndour CT, Faye B, Alifrangis M, et al. The association between malaria parasitaemia, erythrocyte polymorphisms, malnutrition and anaemia in children less than 10 years in Senegal: a case control study. BMC Res Notes. 2012;5:565. doi: 10.1186/1756-0500-5-565 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Mwaiswelo RO, Mmbando BP, Chacky F, Molteni F, Mohamed A, Lazaro S, et al. Malaria infection and anemia status in under-five children from Southern Tanzania where seasonal malaria chemoprevention is being implemented. Carvalho LH, editor. PLoS ONE. 2021;16:e0260785. doi: 10.1371/journal.pone.0260785 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Ngasala B, Matata F, Mwaiswelo R, Mmbando BP. Anemia among Schoolchildren with Malaria and Soil-Transmitted Helminth Coinfections after Repeated Rounds of Mass Drug Administration in Muheza District, Tanzania. The American Journal of Tropical Medicine and Hygiene. 2019;101:1148–55. doi: 10.4269/ajtmh.19-0362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Kateera F, Ingabire CM, Hakizimana E, Kalinda P, Mens PF, Grobusch MP, et al. Malaria, anaemia and under-nutrition: three frequently co-existing conditions among preschool children in rural Rwanda. Malar J. 2015;14:440. doi: 10.1186/s12936-015-0973-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Mbunga BK, Mapatano MA, Strand TA, Gjengedal ELF, Akilimali PZ, Engebretsen IMS. Prevalence of Anemia, Iron-Deficiency Anemia, and Associated Factors among Children Aged 1–5 Years in the Rural, Malaria-Endemic Setting of Popokabaka, Democratic Republic of Congo: A Cross-Sectional Study. Nutrients. 2021;13:1010. doi: 10.3390/nu13031010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Kebede D, Getaneh F, Endalamaw K, Belay T, Fenta A. Prevalence of anemia and its associated factors among under-five age children in Shanan gibe hospital, Southwest Ethiopia. BMC Pediatr. 2021;21:542. doi: 10.1186/s12887-021-03011-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Gaston RT, Habyarimana F, Ramroop S. Joint modelling of anaemia and stunting in children less than five years of age in Lesotho: a cross-sectional case study. BMC Public Health. 2022;22:285. doi: 10.1186/s12889-022-12690-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Rahman MS, Mushfiquee M, Masud MS, Howlader T. Association between malnutrition and anemia in under-five children and women of reproductive age: Evidence from Bangladesh Demographic and Health Survey 2011. Adu-Afarwuah S, editor. PLoS ONE. 2019;14:e0219170. doi: 10.1371/journal.pone.0219170 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Ngesa O, Mwambi H. Prevalence and Risk Factors of Anaemia among Children Aged between 6 Months and 14 Years in Kenya. Stoute JA, editor. PLoS ONE. 2014;9:e113756. doi: 10.1371/journal.pone.0113756 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Yeka A, Nankabirwa J, Mpimbaza A, Kigozi R, Arinaitwe E, Drakeley C, et al. Factors Associated with Malaria Parasitemia, Anemia and Serological Responses in a Spectrum of Epidemiological Settings in Uganda. Ng LFP, editor. PLoS ONE. 2015;10:e0118901. doi: 10.1371/journal.pone.0118901 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Adebo AA, Yessoufou AG, Behanzin JG, Kabanoude AA, Yessoufou AK. Anémie chez les enfants de moins de 5 ans reçus en consultation au service de pédiatrie de l’Hôpital de Zone d’Abomey-Calavi/So-Ava (Sud du Bénin). J App Bioscience. 2018;123:12373. [Google Scholar]
  • 47.Gosdin L, Tripp K, Mahama AB, Quarshie K, Amoaful EF, Selenje L, et al. Predictors of anaemia among adolescent schoolchildren of Ghana. J Nutr Sci. 2020;9:e43. doi: 10.1017/jns.2020.35 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Solovyova AV, Gace V, Ermolenko KS, Khorolskiy VA. Anemia in Women of Reproductive Age. In: Khan J, editor. Current Topics in Anemia [Internet]. InTech; 2018. [cited 2022 Oct 18]. Available from: http://www.intechopen.com/books/current-topics-in-anemia/anemia-in-women-of-reproductive-age [Google Scholar]

Decision Letter 0

Sylla Thiam

9 Jan 2024

PONE-D-23-41641Malaria prevalence and use of control measures in an area with persistent transmission in SenegalPLOS ONE

Dear Dr. Tairou,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Feb 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Sylla Thiam, M.D, MPH

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf.

2. Thank you for stating in your Funding Statement:

“The study was supported by the Senegalese National Malaria Control Program, through an agreement with the Department of Parasitology and Mycology of University Cheikh Anta Diop of Dakar (# funding number: NFM 2-SEN-M-PNLP 2018 - 2019 -2020). The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now.  Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Please include a separate caption for each figure in your manuscript.

5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

 a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

Additional Editor Comments (if provided):

The paper is very relevant and timely. The study is well designed and easily explained. The manuscript is well written in a very simple and accessible language.

Results are well presented with their respective public health implications. Lastly key recommandations are given to strenghten malaria surveillance in all age groupes and support national effort towards malaria elimination.

However, Saraya being a high transmission area where SMC is implemented since almost 10 years, we cannot understand that SMC data was not collected among children under 10 years.

The authors did not give any explanation on the absence of SMC data during data collection and analysis.

The absence of SMC data is a major limit that needs to be adressed by the authors.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This study was conducted in a high malaria transmission area of Senegal, the district of Saraya where seasonal malaria chemoprevention (SMC) is implemented for children under 10 years of age. In Saraya district’s, under 10 children receive monthly a curative dose of antimalarial during the malaria transmission season from June to October.

Why don’t the authors include the SMC coverage in their data collection?

Is the low prevalence of asymptomatic and symptomatic malaria in children under 10 not due to SMC?

I think that conducting a malaria prevalence study in an area like Saraya should take into account the coverage rate for a better interpretation of the results.

I recommend that authors include the CMS coverage rate in their data collection.

Corrections are also needed for Plasmodium species. P. falciparum instead of P. Falciparum

Reviewer #2: General Comment: The title of the manuscript is suitable and relevant to the health challenges ravaging the sub-Sahara subregion of the world. The research is well-conceived and executed. The language of communication and the grammar are good. The methodology and data analysis are explicit. The result is well presented in tables and figures. The discussion is well written. References are ok. However, there are a few issues for clarification.

Abstract:

Page 3 Line 50-51 & 56-57. There are discrepancies between the statement on malaria by age group.

Line 50-51. “There was no statistical difference in malaria infection by age group.”

Line 56-57. “Participants aged 5-9 years were more likely to have malaria infection compared to under five children (aOR=1.40, 95% CI:1.02-1.91).”

Introduction:

Page 4. Line 74-78. It was observed that you used different indices for malaria mortality, which did not allow for an easy comparison of the trend in malaria mortality between 2020 and 2022. You are advised to use the same metric for comparison to ensure objectivity.

Method:

Page 6. Line 113. You will need to be explicit on inclusion and exclusion criteria as individuals on antimalaria may be asymptomatic at the time of the recruitment and should have been excluded as they may still harbour the parasite.

Page 7. Line 161-163. Provide a reference for the Senegalese population used to compare the proportion of each age group recruited.

Page 8. Line 183-189. Information on individuals concerned with preparing the smear should be provided. Were they trained?

Page 12. Table 1. The table shows that 43.2% had no occupation, while 25.7% were students. What, then, is the main source of livelihood for most of the populace?

Table1. page 12. Different spellings were used for the “Quranic” school….”Koranic”….”Choranic”. Kindly reconcile the spelling.

Page 14-15. Consistent use of abbreviation for Plasmodium falciparum as P. falciparum. Ensure the same abbreviation after the initial full written form.

Discussion. Ok

Page 22. Line 452-458. The study limitation, which considers the microscopy method used in this community study to be a possibility of missed diagnosis in low-density infection, may need to be revised.

In a study by Berzosa et al. 2018 in Equatorial Guinea, the microscopy used in your research is still recommended by WHO as it is cheap, allows for species differentiation, and is the acclaimed gold standard for diagnosis by WHO.

“Berzosa, P., de Lucio, A., Romay-Barja, M. et al. Comparison of three diagnostic methods (microscopy, RDT, and PCR) for detecting malaria parasites in representative samples from Equatorial Guinea. Malar J 17, 333 (2018). https://doi.org/10.1186/s12936-018-2481-4” three metho

References. Ok

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: BELLO IBRAHIM SEBUTU

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 May 16;19(5):e0303794. doi: 10.1371/journal.pone.0303794.r002

Author response to Decision Letter 0


24 Mar 2024

To PLOS ONE editor

Subject: Response to Reviewers

Ref: PONE-D-23-41641

Malaria prevalence and use of control measures in an area with persistent transmission in Senegal

Dear Editor;

On behalf of the co-authors, I would like to thank the editor and the reviewers for the comments and submit below the point-by-point responses to the concerns raised during the review process:

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf"

Authors’ reply: The manuscript has been revised in accordance with PLOS ONE’s style requirements, including those for file naming

2. Thank you for stating in your Funding Statement:

“The study was supported by the Senegalese National Malaria Control Program, through an agreement with the Department of Parasitology and Mycology of University Cheikh Anta Diop of Dakar (# funding number: NFM 2-SEN-M-PNLP 2018 - 2019 -2020). The funder had no role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript”

Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement.

Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf.

Authors’ reply: The amended statements (see below) have been included in the cover letter:

The study was supported by the Senegalese National Malaria Control Program, through an agreement with the Department of Parasitology and Mycology of University Cheikh Anta Diop of Dakar (# funding number: NFM 2-SEN-M-PNLP 2018 - 2019 -2020). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

Authors’reply: The correct grant number is (NFM 2-SEN-M-PNLP 2018 - 2019 -2020).

4. Please include a separate caption for each figure in your manuscript.

Authors’reply: The manuscript has been revised to reflect separate caption for each figure

5. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

Authors’reply: Fig 1 illustrating the study site was created by one of the co-authors (Mr Libasse Sarr) for this article, and was not previously published anywhere. A permission to publish the figure under the Creative Commons Attribution License (CCAL) CC BY 4.0 is requested from him and the Content Permission Form is submitted along with the revised version of the manuscript.

6. Additional Editor Comments (if provided):

The paper is very relevant and timely. The study is well designed and easily explained. The manuscript is well written in a very simple and accessible language.

Results are well presented with their respective public health implications. Lastly key recommendations are given to strenghten malaria surveillance in all age groupes and support national effort towards malaria elimination. However, Saraya being a high transmission area where SMC is implemented since almost 10 years, we cannot understand that SMC data was not collected among children under 10 years. The authors did not give any explanation on the absence of SMC data during data collection and analysis. The absence of SMC data is a major limit that needs to be adressed by the authors.

Authors’reply: The study collected data on SMC coverage among children under 10 years. These data are presented in the revised version as follow:

According to the report of caregivers/mothers, a proportion of sixty-eight percent (68.8%) of children aged 6 months to 10 years (n=839) received at least one dose of SMC; full coverage of SMC (3 days of treatment for all four rounds) was evaluated at 46.8% (see Table 1, page 13)

Reviewer #1:

1. This study was conducted in a high malaria transmission area of Senegal, the district of Saraya where seasonal malaria chemoprevention (SMC) is implemented for children under 10 years of age. In Saraya district’s, under 10 children receive monthly a curative dose of antimalarial during the malaria transmission season from June to October.

Why don’t the authors include the SMC coverage in their data collection?

I think that conducting a malaria prevalence study in an area like Saraya should take into account the coverage rate for a better interpretation of the results. I recommend that authors include the CMS coverage rate in their data collection.

Authors’reply : The study collected data on SMC coverage among children under 10 years. These data are presented in the revised version as follow:

According to the report of caregivers/mothers, a proportion of sixty-eight percent (68.8%) of children aged 6 months to 10 years (n=839) received at least one dose of SMC; full coverage of SMC (3 days of treatment for all four rounds) was evaluated at 46.8% (see Table 1, page 13)

2. Is the low prevalence of asymptomatic and symptomatic malaria in children under 10 not due to SMC?

Authors’reply: Though SMC data was collected in this study, we did not find any evidence of SMC effect on symptomatic or asymptomatic P. falciparum malaria due to lack of power. Indeed, assessing SMC effect on symptomatic and asymptomatic infections, will require subgroup analysis with restrictions on SMC targets who were found with P. falciparum infections either symptomatic or asymptomatic (N=198). This prevalence study was designed to assess malaria prevalence at all age group but was not powered to detect an effect of SMC on symptomatic or asymptomatic malaria.

3. Corrections are also needed for Plasmodium species. P. falciparum instead of P. Falciparum

Authors’reply: Plasmodium species “P. falciparum” has been harmonized throughout the manuscript

Reviewer #2:

1. Abstract:

Page 3 Line 50-51 & 56-57. There are discrepancies between the statement on malaria by age group.

Line 50-51. “There was no statistical difference in malaria infection by age group.”

Line 56-57. “Participants aged 5-9 years were more likely to have malaria infection compared to under five children (aOR=1.40, 95% CI:1.02-1.91).”

Authors’reply: The authors agreed with the reviewer.

Line 50-51 refer to univariate analysis and this has showed a significant effect of age on malaria prevalence (specifically between children aged 5-10 years old and adults aged �20 years old). To avoid confusion with the multivariate analysis, the manuscript is revised and the sentence in Line 50-51 is removed.

2. Introduction:

Page 4. Line 74-78. It was observed that you used different indices for malaria mortality, which did not allow for an easy comparison of the trend in malaria mortality between 2020 and 2022. You are advised to use the same metric for comparison to ensure objectivity.

Authors’reply: This section has been revised in the manuscript. “Mortality rate” is used to compare malaria mortality between 2020-2022 (Please, see Line 78-80)

3. Method:

Page 6. Line 113. You will need to be explicit on inclusion and exclusion criteria as individuals on antimalaria may be asymptomatic at the time of the recruitment and should have been excluded as they may still harbour the parasite.

Authors’reply: The manuscript has been revised to take into account the reviewer’s comment; inclusion and exclusion criteria considered during the recruitment are added to the revised manuscript (Please, see Line 126-130).

Page 7. Line 161-163. Provide a reference for the Senegalese population used to compare the proportion of each age group recruited.

Authors’reply: The reference for the Senegalese population used for the proportion of each age group is provided in the revised manuscript (Please, see Line 172).

Page 8. Line 183-189. Information on individuals concerned with preparing the smear should be provided. Were they trained?

Authors’reply: Individuals involved in the preparation of the smear were trained on the sample collection and the preparation of the smears. The manuscript is revised to reflect this information Please, see Line 201-204).

Page 12. Table 1. The table shows that 43.2% had no occupation, while 25.7% were students. What, then, is the main source of livelihood for most of the populace?

Authors’reply: In the study area, the main source of livelihood for most of the population is farming and gold mining . This figure is well represented among adults in the study population, with around 60% (farming 21.2% and gold mining 38.4%) (Please, see Table 1).

Table1. page 12. Different spellings were used for the “Quranic” school….”Koranic”….”Choranic”. Kindly reconcile the spelling.

Authors’reply: The manuscript is revised and “Koranic school” is used throughout the document.

Page 14-15. Consistent use of abbreviation for Plasmodium falciparum as P. falciparum. Ensure the same abbreviation after the initial full written form.

Authors’reply: The manuscript is revised in accordance. P. falciparum has been used throughout the manuscript as abbreviation for Plasmodium falciparum.

4. Discussion.

Page 22. Line 452-458. The study limitation, which considers the microscopy method used in this community study to be a possibility of missed diagnosis in low-density infection, may need to be revised.

In a study by Berzosa et al. 2018 in Equatorial Guinea, the microscopy used in your research is still recommended by WHO as it is cheap, allows for species differentiation, and is the acclaimed gold standard for diagnosis by WHO.

“Berzosa, P., de Lucio, A., Romay-Barja, M. et al. Comparison of three diagnostic methods (microscopy, RDT, and PCR) for detecting malaria parasites in representative samples from Equatorial Guinea. Malar J 17, 333 (2018). https://doi.org/10.1186/s12936-018-2481-4” three metho

Authors’reply: The authors would like to thank the reviewer for this comment. This limitation has been removed from the revised manuscript (Please, see Line 512-513).

Attachment

Submitted filename: Response to Reviewers..docx

pone.0303794.s005.docx (32.9KB, docx)

Decision Letter 1

Sylla Thiam

1 May 2024

Malaria prevalence and use of control measures in an area with persistent transmission in Senegal

PONE-D-23-41641R1

Dear Dr. Tairou

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Sylla Thiam, M.D, MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement—checklist of items that should be included in reports of cross-sectional studies.

    (DOCX)

    pone.0303794.s001.docx (31.7KB, docx)
    S1 File. French version of the study questionnaire.

    (DOCX)

    pone.0303794.s002.docx (44KB, docx)
    S2 File. English version of the study questionnaire.

    (DOCX)

    pone.0303794.s003.docx (33.1KB, docx)
    S1 Dataset. Prevalence survey excel dataset.

    (XLSX)

    pone.0303794.s004.xlsx (1.8MB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers..docx

    pone.0303794.s005.docx (32.9KB, docx)

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES